Lipigon Pharmaceuticals AB's total assets for Q2 2025 were kr26.57M, a decrease of -27.04% from the previous quarter. DE:9RP total liabilities were kr4.11M for the fiscal quarter, a -42.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.